Tony Hebden, VP HEOR, AbbVie
Dr. Hebden joined AbbVie in 2013 as Vice President of Global Health Economics and Outcomes Research. As a senior leader at AbbVie, he sits on a number of key decision making bodies responsible for deﬁning the current and future direction of the company. Prior to joining Abbvie, Tony held several leadership roles at Bristol Myers Squibb in Princeton New Jersey, including Executive Director, Health Economics and Outcomes Research and Global Head of Medical Affairs for Clopidogrel (Plavix).
Dr. Hebden attended The University of London where he received a BSc (Hons) in Physiology and MSc in Applied Physiology, and The University of Nottingham where he received a PhD in Pharmacology. Following this he completed a post-doctoral fellowship at The University of British Columbia, Canada and a second at Tripler Army Medical Center, Hawaii, before taking a faculty position at the University of Ottawa Heart Institute. He has over 100 scientiﬁc publications in the areas of cardiovascular and renal physiology and pharmacology as well as Health Economics and Outcomes Research.